You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 111 No. 8, August 1975 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (48)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Toxic Epidermal Necrolysis Associated With Allopurinol Administration

Michael H. Ellman, MD; David F. Fretzin, MD; Walter Olson, MD

Arch Dermatol. 1975;111(8):986-990.


Abstract



Allopurinol, now established as a standard form of therapy in hyperuricemia and gout, may be associated with life-threatening skin reactions. This study reports the occurrence of toxic epidermal necrolysis (TEN) in three patients receiving allopurinol. The patients had complicated medical illnesses and were receiving various other medications, but the most apparent common denominator was allopurinol ingestion. Two other cases of TEN and five cases of severe hypersensitivity reactions with vasculitis and extensive skin manifestations, secondary to this drug, have been described in the recent literature. Allopurinol has several unique biochemical and metabolic properties that may increase its ability to cause hypersensitivity or toxic skin reactions.



Author Affiliations



From the Department of Medicine, divisions of rheumatology (Drs. Ellman and Olson) and dermatology (Dr. Fretzin), Michael Reese Medical Center, Chicago.


Footnotes



Accepted for publication Jan 3, 1975.

Reprint requests to 2929 S Ellis Ave, Chicago, IL 60616 (Dr. Ellman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Allopurinol-Induced Stevens-Johnson Syndrome
Ashworth
Journal of Pharmacy Practice 1992;5:ix-x.
 

Toxic Epidermal Necrolysis: Clinical Findings and Prognosis Factors in 87 Patients
Revuz et al.
Arch Dermatol 1987;123:1160-1165.
ABSTRACT  

Ethambutol-Induced Toxic Epidermal Necrolysis
Pegram et al.
Arch Intern Med 1981;141:1677-1678.
ABSTRACT  

Allopurinol-Induced Arteritis in Partial HGPRTase Deficiency: Atypical Seizure Manifestation
Weiss et al.
Arch Intern Med 1978;138:1743-1744.
ABSTRACT  

Ocular Manifestations of Toxic Epidermal Necrolysis Associated With Allopurinol Use
Bennett et al.
Arch Ophthalmol 1977;95:1362-1364.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.